{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:02:03Z","timestamp":1787724123423,"version":"build-2784847793"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.seizure.2015.03.006","type":"journal-article","created":{"date-parts":[[2015,3,31]],"date-time":"2015-03-31T01:38:56Z","timestamp":1427765936000},"page":"66-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"special_numbering":"C","title":["Interactions between hormonal contraception and antiepileptic drugs: Clinical and mechanistic considerations"],"prefix":"10.1016","volume":"28","author":[{"given":"Arne","family":"Reimers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eylert","family":"Brodtkorb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Sabers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2015.03.006_bib0275","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1474-4422(12)70103-5","article-title":"Teratogenic effects of antiepileptic drugs","volume":"11","author":"Tomson","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.seizure.2015.03.006_bib0280","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jocn.2013.09.022","article-title":"Effect of anti-epileptic drug therapy on the unborn child","volume":"21","author":"Vajda","year":"2014","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.seizure.2015.03.006_bib0285","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1212\/WNL.46.6.1534","article-title":"Antiepileptic medication and oral contraceptive interactions: a national survey of neurologists and obstetricians","volume":"46","author":"Krauss","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2015.03.006_bib0290","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/jnnp.72.1.114","article-title":"Antiepileptic drugs: coprescription of proconvulsant drugs and oral contraceptives: a national study of antiepileptic drug prescribing practice","volume":"72","author":"Shorvon","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.seizure.2015.03.006_bib0295","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S1059-1311(03)00085-2","article-title":"Understanding the information needs of women with epilepsy at different lifestages: results of the \u2018Ideal World\u2019 survey","volume":"12","author":"Crawford","year":"2003","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2015.03.006_bib0300","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/j.1528-1167.2005.04205.x","article-title":"Management of women with epilepsy: are guidelines being followed? Results from case-note reviews and a patient questionnaire","volume":"46","author":"Kampman","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2015.03.006_bib0305","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.yebeh.2004.11.006","article-title":"Knowledge of women's issues and epilepsy (KOWIE-II): a survey of health care professionals","volume":"6","author":"Long","year":"2005","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2015.03.006_bib0310","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.yebeh.2009.01.024","article-title":"Antiepileptic drugs: are women aware of interactions with oral contraceptives and potential teratogenicity?","volume":"14","author":"Pack","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2015.03.006_bib0315","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0920-1211(02)00135-3","article-title":"Information recalled by women taking anti-epileptic drugs for epilepsy: a questionnaire study","volume":"52","author":"Bell","year":"2002","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2015.03.006_bib0320","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1528-1157.1979.tb04834.x","article-title":"Do anticonvulsants reduce the efficacy of oral contraceptives?","volume":"20","author":"Coulam","year":"1979","journal-title":"Epilepsia"},{"issue":"Suppl. A","key":"10.1016\/j.seizure.2015.03.006_bib0325","doi-asserted-by":"crossref","first-page":"A30","DOI":"10.1016\/S0149-2918(98)80023-4","article-title":"Pregnancy and quality of life in women with epilepsy","volume":"20","author":"Kaneko","year":"1998","journal-title":"Clin Ther"},{"key":"10.1016\/j.seizure.2015.03.006_bib0330","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/bmj.321.7262.674","article-title":"Population based, prospective study of the care of women with epilepsy in pregnancy","volume":"321","author":"Fairgrieve","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.seizure.2015.03.006_bib0335","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.beem.2012.11.004","article-title":"History of oral contraceptive drugs and their use worldwide","volume":"27","author":"Christin-Maitre","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.seizure.2015.03.006_bib0340","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.contraception.2012.08.002","article-title":"Contraception technology: past, present and future","volume":"87","author":"Sitruk-Ware","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.seizure.2015.03.006_bib0345","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.0001-6349.2005.00759.x","article-title":"Role of progestins in contraception","volume":"84","author":"Erkkola","year":"2005","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.seizure.2015.03.006_bib0350","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2147\/IJWH.S65481","article-title":"Noncontraceptive benefits of the estradiol valerate\/dienogest combined oral contraceptive: a review of the literature","volume":"6","author":"Nappi","year":"2014","journal-title":"Int J Womens Health"},{"issue":"Suppl. 1","key":"10.1016\/j.seizure.2015.03.006_bib0355","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/13697130500148875","article-title":"Pharmacology of estrogens and progestogens: influence of different routes of administration","volume":"8","author":"Kuhl","year":"2005","journal-title":"Climacteric"},{"key":"10.1016\/j.seizure.2015.03.006_bib0360","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ajog.2005.12.045","article-title":"Long-term safety of an extended-cycle oral contraceptive (Seasonale): a 2-year multicenter open-label extension trial","volume":"195","author":"Anderson","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.seizure.2015.03.006_bib0365","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.gyobfe.2013.05.003","article-title":"Reducing the frequency of menses: extended contraception, a review","volume":"41","author":"This","year":"2013","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.seizure.2015.03.006_bib0370","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.seizure.2007.11.013","article-title":"Which contraception for women with epilepsy?","volume":"17","author":"Schwenkhagen","year":"2008","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2015.03.006_bib0375","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0378-5122(82)90064-0","article-title":"Pharmacokinetic and pharmacological features of oestradiol valerate","volume":"4","author":"Dusterberg","year":"1982","journal-title":"Maturitas"},{"key":"10.1016\/j.seizure.2015.03.006_bib0380","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2125.1981.tb00534.x","article-title":"The in vitro metabolism of ethinyloestradiol, mestranol and levonorgestrel by human jejunal mucosa","volume":"11","author":"Back","year":"1981","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.seizure.2015.03.006_bib0385","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1124\/dmd.104.000182","article-title":"The involvement of CYP3A4 and CYP2C9 in the metabolism of 17 alpha-ethinylestradiol","volume":"32","author":"Wang","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.seizure.2015.03.006_bib0390","first-page":"5","article-title":"Drug interaction with oral contraceptives","volume":"2","author":"Hillier","year":"1978","journal-title":"Fertil Contracept"},{"key":"10.1016\/j.seizure.2015.03.006_bib0395","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2165\/00003088-200746020-00003","article-title":"Pharmacokinetic drug interactions involving 17alpha-ethinylestradiol: a new look at an old drug","volume":"46","author":"Zhang","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.seizure.2015.03.006_bib0400","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0920-1211(01)00305-9","article-title":"Lamotrigine plasma levels reduced by oral contraceptives","volume":"47","author":"Sabers","year":"2001","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2015.03.006_bib0405","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0010-7824(80)90102-X","article-title":"The interaction of phenobarbital and other anticonvulsants with oral contraceptive steroid therapy","volume":"22","author":"Back","year":"1980","journal-title":"Contraception"},{"key":"10.1016\/j.seizure.2015.03.006_bib0410","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1365-2125.1990.tb05457.x","article-title":"The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids","volume":"30","author":"Crawford","year":"1990","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.seizure.2015.03.006_bib0415","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1136\/jnnp.41.10.913","article-title":"Effect of anticonvulsants on plasma testosterone and sex hormone binding globulin levels","volume":"41","author":"Barragry","year":"1978","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.seizure.2015.03.006_bib0420","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1528-1157.1995.tb01011.x","article-title":"Carbamazepine, phenytoin, sex hormones, and sexual function in men with epilepsy","volume":"36","author":"Isojarvi","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2015.03.006_bib0425","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0009-9236(95)90172-8","article-title":"Effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptive","volume":"58","author":"Saano","year":"1995","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.seizure.2015.03.006_bib0430","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1046\/j.1528-1157.2003.55602.x","article-title":"Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects","volume":"44","author":"Doose","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2015.03.006_bib0435","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1528-1157.1997.tb01123.x","article-title":"Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy","volume":"38","author":"Rosenfeld","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2015.03.006_bib0440","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1528-1157.1999.tb00779.x","article-title":"Induction of ethinylestradiol and levonorgestrel metabolism by oxcarbazepine in healthy women","volume":"40","author":"Fattore","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2015.03.006_bib0445","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1528-1167.2012.03519.x","article-title":"Pharmacokinetics and drug interactions of eslicarbazepine acetate","volume":"53","author":"Bialer","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2015.03.006_bib0450","series-title":"Fycompa prescribing information","year":"2014"},{"key":"10.1016\/j.seizure.2015.03.006_bib0455","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0010-7824(86)90028-4","article-title":"The lack of effect of sodium valproate on the pharmacokinetics of oral contraceptive steroids","volume":"33","author":"Crawford","year":"1986","journal-title":"Contraception"},{"key":"10.1016\/j.seizure.2015.03.006_bib0460","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1212\/WNL.50.4.1146","article-title":"Gabapentin does not interact with a contraceptive regimen of norethindrone acetate and ethinyl estradiol","volume":"50","author":"Eldon","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2015.03.006_bib0465","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1046\/j.1528-1157.2002.57701.x","article-title":"Levetiracetam does not alter the pharmacokinetics of an oral contraceptive in healthy women","volume":"43","author":"Ragueneau-Majlessi","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2015.03.006_bib0470","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1016\/j.clinthera.2004.11.019","article-title":"Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women","volume":"26","author":"Griffith","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.seizure.2015.03.006_bib0475","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1528-1167.2007.00983.x","article-title":"Pharmacokinetics and drug interactions with zonisamide","volume":"48","author":"Sills","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2015.03.006_bib0480","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/epi.12085","article-title":"Pharmacodynamic and pharmacokinetic evaluation of coadministration of lacosamide and an oral contraceptive (levonorgestrel plus ethinylestradiol) in healthy female volunteers","volume":"54","author":"Cawello","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2015.03.006_bib0485","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2125.2005.02539.x","article-title":"The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects","volume":"61","author":"Sidhu","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.seizure.2015.03.006_bib0490","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1212\/01.wnl.0000344167.78102.f0","article-title":"Valproate and lamotrigine level variation with menstrual cycle phase and oral contraceptive use","volume":"72","author":"Herzog","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2015.03.006_bib0495","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/j.1528-1167.2006.00629.x","article-title":"Increased apparent oral clearance of valproic acid during intake of combined contraceptive steroids in women with epilepsy","volume":"47","author":"Galimberti","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2015.03.006_bib0500","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1528-1167.2007.00997.x","article-title":"Oral contraceptives induce lamotrigine metabolism: evidence from a double-blind, placebo-controlled trial","volume":"48","author":"Christensen","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2015.03.006_bib0505","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1111\/j.1528-1167.2005.10105.x","article-title":"Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations","volume":"46","author":"Reimers","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2015.03.006_bib0510","doi-asserted-by":"crossref","first-page":"847","DOI":"10.5414\/CP201916","article-title":"The effect of ezogabine on the pharmacokinetics of an oral contraceptive agent","volume":"51","author":"Crean","year":"2013","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.seizure.2015.03.006_bib0515","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.eplepsyres.2011.04.001","article-title":"No effect of oral contraceptives on the metabolism of levetiracetam","volume":"95","author":"Sabers","year":"2011","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2015.03.006_bib0520","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/j.1528-1167.2006.00507.x","article-title":"Hormone replacement therapy in women with epilepsy: a randomized, double-blind, placebo-controlled study","volume":"47","author":"Harden","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2015.03.006_bib0525","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0010-7824(86)90044-2","article-title":"Contraception by Norplant subdermal capsules is not reliable in epileptic patients on anticonvulsant treatment","volume":"33","author":"Haukkamaa","year":"1986","journal-title":"Contraception"},{"key":"10.1016\/j.seizure.2015.03.006_bib0530","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.eplepsyres.2011.02.002","article-title":"Lamotrigine and its N2-glucuronide during pregnancy: the significance of renal clearance and estradiol","volume":"94","author":"Reimers","year":"2011","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2015.03.006_bib0535","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/j.1875-9114.1998.tb03161.x","article-title":"Enhanced metabolism of levonorgestrel during phenobarbital treatment and resultant pregnancy","volume":"18","author":"Shane-McWhorter","year":"1998","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.seizure.2015.03.006_bib0540","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1528-1167.2008.01665.x","article-title":"Rufinamide: clinical pharmacokinetics and concentration\u2013response relationships in patients with epilepsy","volume":"49","author":"Perucca","year":"2008","journal-title":"Epilepsia"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105913111500076X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105913111500076X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:45:41Z","timestamp":1761011141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105913111500076X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":54,"alternative-id":["S105913111500076X"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2015.03.006","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interactions between hormonal contraception and antiepileptic drugs: Clinical and mechanistic considerations","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2015.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}